http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Pyae Pa Pa Kyaw,Brian K. P. Goh 한국간담췌외과학회 2019 Annals of hepato-biliary-pancreatic surgery Vol.23 No.2
Completion pancreatectomy (CP), is an effective, and potentially curative option for selected patients with local recurrence of pancreatic neoplasms in the remnant pancreas after initial pancreatoduodenectomy (PD). Traditionally CP has been performed via the open approach. Reports of minimally-invasive CP particularly after previous open PD are rare. We present a case of a 72-year old male who previously underwent open PD 5 years ago for intraductal papillary mucinous neoplasm (IPMN) with high grade dysplasia in the uncinate process. He had multifocal IPMN and low-risk lesions in the body and tail were managed conservatively. On routine surveillance, the cyst in the body was noted to be increasing in size with the development of a non-enhancing solid component confirmed on magnetic resonance imaging and subsequent endoscopic ultrasonography. The patient underwent successful robotic assisted laparoscopic completion pancreatectomy. Final histology confirmed a recurrent IPMN with low-to-intermediate grade dysplasia. The postoperative recovery was uneventful and he was discharged on postoperative day 9.
Survey on Liver Resection Cases (2 Year Myanmar Experience)
( Min Htin ),( Pyae Pa Pa Kyaw ),( Tin Tin Mar ) 대한간학회 2017 춘·추계 학술대회 (KASL) Vol.2017 No.1
Aims: According to the 2015 concensus (1), Myanmar population has Hepatitis C carrier of 2-4% and Hepatitis B of above 8%. Hepatocellular Carcinoma prevalence is therefore the high and it also impose significant burden to the health of our population. Our department, although founded three years ago, had to encounter with it and the resection rate is between 50-100 per year. Methods: Descriptive study based on telephone interview of resected and transplanted patients for Hepatocellular Carcinoma within two years, 2015 and 2016, focusing on recurrence and survival. Results: 57 and 95 cases of Hepatocellular Carcinoma patients underwent various types of operation from wedge resection to Transplantation. The response rate is 21% for 2015 and 56% for 2016. Sex distribution is approximately 3:1 ( Male : Female). 51 to 60 year group is the most affected age group for both years. For 2015, survival rate is only 10% and all survivor had recurrence. For 2016, survival rate is 74% and only 24% of the survivor had recurrence. Conclusions: Although the initial results of our department on treating Hepatocellular carcinoma shows improvement, it still need improvement to catch up with international figures